Dymon Asia Capital »

Axsome Therapeutics shares owned by Dymon Asia Capital

Quarter-by-quarter ownership of Axsome Therapeutics (AXSM) shares owned by Dymon Asia Capital from 13F filings

Historical chart of Dymon Asia Capital investment in Axsome Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Axsome Therapeutics held by Dymon Asia Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Axsome Therapeutics by Dymon Asia Capital

Quarter filed Position value Share count Share price at filing
2026-06-30 $979k 4.0k 244.77

More positions owned by Dymon Asia Capital

Vaneck Etf Trust Semiconductr Etf (SMH)
Ishares Msci Sth Kor Etf Put Option (EWY)
Roundhill Etf Trust Memory Etf Put Option
State Str Spdr S&p 500 Etf T Tr Unit Call Option (SPY)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
Micron Technology (MU)
Intel Corporation Put Option (INTC)
Nokia Corp Sponsored Adr (NOK)
Seagate Technology Hldngs Pl Ord Shs (STX)
Delek Us Holdings (DK)
Advanced Micro Devices Put Option (AMD)
NVIDIA Corporation Call Option (NVDA)
Alphabet Cap Stk Cl A Call Option (GOOGL)
UnitedHealth Put Option (UNH)
Valero Energy Corporation (VLO)

View all positions for Dymon Asia Capital

Top funds holding Axsome Therapeutics

BlackRock
Vanguard Portfolio Management
Vanguard Capital Management
Invesco
FMR
T. Rowe Price Associates
State Street Corporation
Geode Capital Management
Susquehanna International
Jane Street
Deep Track Capital
Two Sigma Investments
Franklin Resources
Wellington Management Company
D. E. Shaw & Co

View all funds holding Axsome Therapeutics